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Letter to Editor 
 
A new delivery model to increase adherence to methadone 
 maintenance treatment 
 
Dear Editor, 
Today, a large number of Iranian addicts are treated in 
methadone maintenance treatment (MMT) centers (1). 
According to the current procedure, each patient has 
treatment record in only one clinic. So, each patient is able to 
get prescribed medications and other medical services of the 
center. Receiving drugs and center-based services has always 
faced serious challenges such as access (2). For example, 
some patients with mobility jobs, people with movement 
restrictions and physical conditions, and patients living in 
rural and remote areas are unable to refer to get the 
medication according to a regular timetable (3). The 
mentioned issues are a serious challenge for persistence and 
adherence to MMT. Under such circumstances, a significant 
proportion of patients abandoned treatment plan and they 
lost the ancillary services, including medical visits, 
psychological interventions, and physical and emotional 
support from a social worker. Ultimately, this situation led to 
an increased the risk of relapse and resume high risk 
behaviors related to substance abuse (4). Social damage and 
financial losses of the country's health system are only some 
of the negative consequences of this situation. 
Based on these considerations, presentation of the 
strategies and constructive recommendations in support of 
the related organizations is a necessity. Despite the several 
offers raised, it seems that the abolition of the system 
receiving drugs from the origin center and the use of digital 
identification systems can be useful and practical (5). In the 
form of drug delivery system, patients can receive their daily 
dosages in any of the center across the country. This project 
is done in such a manner that each patient first enrolls in an 
MMT center and fills out a medical record form. Then, the 
doctor will determine the types of medication and drug dose 
based on the patients’ medication history. In the first three 
months of treatment (i.e. until the stabilization of the dose), 
visits or appointments will be face to face. After the period 
and stabilized drug dose, the patient who receives 
medication is no longer confined to the origin center. This 
means that each patient is issued an entity identifier such as a  
 
smart card for medication. By issuing the smart card, the 
patient can receive quota set medication use in any part of 
the country. Definitely to prevent abuse of patients, it is 
recommended that the patient's identity be verified through 
the finger, eye, or facial recognition digital sensors (5). 
Meanwhile, bringing up an instruction can be useful based 
on a mandatory visit to the center of origin for medical 
examination and psychological services at least once a 
month. 
So far, few studies have been conducted to review and 
confirm the delivery format of pharmaceutical services (6, 
7). However, previous studies show that the facial 
assessment via computer evaluation and photo 
anthropometric variations in facial features are standard 
references for personal identification in the field of health 
and forensic (8, 9). Thus, our offer could possibly be 
effective in increasing adherence to treatment and reducing 
problems caused by the access to origin MMT center. As a 
result, we recommend using this pilot model for at least a 
one-year period. Then, if the benefit of this model is in 
practice, this proposal could be implemented permanently. 
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